Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick Clifton-Bligh

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Nature Reviews. Endocrinology|August 13, 2025
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescentsRuth T Casey, Emile Hendriks, Cheri Deal, et al.
Nature Reviews. Endocrinology|August 15, 2024
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescentsRuth T Casey, Emile Hendriks, Cheri Deal, et al.
Nature Reviews. Endocrinology|August 27, 2024
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescentsRuth T Casey, Emile Hendriks, Cheri Deal, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2023
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter StudyBin Xu, Kartik Viswanathan, Mahsa S Ahadi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2015
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer VariantsXiaoguang Shi, Rengyun Liu, Fulvio Basolo, et al.
Nature Reviews. Endocrinology|December 14, 2023
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementDavid Taïeb, Svenja Nölting, Nancy D Perrier, et al.
The Lancet. Diabetes & Endocrinology|April 3, 2023
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variantsDavid Taïeb, George B Wanna, Maleeha Ahmad, et al.
Cancer Discovery|June 9, 2025
Federated Deep Learning Enables Cancer Subtyping by ProteomicsZhaoxiang Cai, Emma L Boys, Zainab Noor, et al.
Cancer Discovery|April 8, 2025
Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High AltitudesCarlota Arenillas, Lucía Celada, José Ruiz-Cantador, et al.
Cell Reports|February 27, 2024
The genomic and evolutionary landscapes of anaplastic thyroid carcinomaPeter Y F Zeng, Stephenie D Prokopec, Stephen Y Lai, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Nature Reviews. Endocrinology|August 13, 2025
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescentsRuth T Casey, Emile Hendriks, Cheri Deal, et al.
Nature Reviews. Endocrinology|August 15, 2024
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescentsRuth T Casey, Emile Hendriks, Cheri Deal, et al.
Nature Reviews. Endocrinology|August 27, 2024
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescentsRuth T Casey, Emile Hendriks, Cheri Deal, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2023
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter StudyBin Xu, Kartik Viswanathan, Mahsa S Ahadi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2015
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer VariantsXiaoguang Shi, Rengyun Liu, Fulvio Basolo, et al.
Nature Reviews. Endocrinology|December 14, 2023
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementDavid Taïeb, Svenja Nölting, Nancy D Perrier, et al.
The Lancet. Diabetes & Endocrinology|April 3, 2023
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variantsDavid Taïeb, George B Wanna, Maleeha Ahmad, et al.
Cancer Discovery|June 9, 2025
Federated Deep Learning Enables Cancer Subtyping by ProteomicsZhaoxiang Cai, Emma L Boys, Zainab Noor, et al.
Cancer Discovery|April 8, 2025
Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High AltitudesCarlota Arenillas, Lucía Celada, José Ruiz-Cantador, et al.
Cell Reports|February 27, 2024
The genomic and evolutionary landscapes of anaplastic thyroid carcinomaPeter Y F Zeng, Stephenie D Prokopec, Stephen Y Lai, et al.
Pageof 14